Evaluation of Laboratory, Clinical and Treatment Results in Patients with Uncomplicated Brucellosis

ArticleAçık Erişim

Özet

Introduction: Brucellosis is a zoonotic infectious disease endemic in our country and affects all systems. We aimed to evaluate clinical, laboratory findings and treatment outcomes of uncomplicated brucellosis in our study. Materials and Methods: Patients with uncomplicated brucellosis and with no relapse were evaluated from four different cities. Demographic data, clinical, laboratory and radiological findings of follow-up and treatment of 101 patients were recorded in forms. Clinical response (healing, treatment failure, relapse, etc.), treatment side effects, compliance and treatment discontinuation were evaluated at one-year follow-up. Results: The most common risk factors for brucellosis were detected respectively as fresh cheese/dairy product consumption (82.2%), rural area life (71.3%), brucellosis in family and surroundings (42.6%), animal husbandry (27.7%), and brucellosis in animals (24.8%). 80.2% of the patients were evaluated as acute brucellosis. Clinically, fatigue, sweating, loss of appetite, fever, body aches, arthralgia; elevated erythrocyte sedimentation rate, elevated C-reactive protein, elevated liver function tests, anemia and thrombocytopenia were the most frequent findings in laboratory examinations, respectively. In patients with brucellosis, blood culture positivity was 68%, Rose Bengal slide agglutination test was 97.1%, and tube agglutinin test positivity was 96.8%. The most preferred treatment regimen (90%) was doxycycline and rifampicin for 45 days, and treatment response was 89%. In five of the patients, treatment was changed due to doxycycline-linked gastrointestinal side effects. Relapses were seen in 4.9% of all patients. Conclusion: In brucellosis, delay in diagnosis increases the incidence of complications and the tendency to become chronic. For this reason, brucellosis must be considered in patients referred to health institutions with complaints such as fever, sweating and joint pain. Since uncomplicated brucellosis was evaluated in this study, it was seen that the majority of the patients were acute onset and had a high response rate to treatment.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/16957Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5578/flora.68436Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTurken, Melda
dc.contributor.authorPamukcuoglu, Serap Sevim
dc.contributor.authorKarakecili, Faruk
dc.contributor.authorTunca, Berivan
dc.contributor.authorCelik, Didem
dc.contributor.authorKose, Sukran
dc.date.accessioned2026-10-18T20:41:10.229725995Z
dc.date.available2026-10-18T20:41:10.229725995Z
dc.date.issued2020
dc.description.abstractIntroduction: Brucellosis is a zoonotic infectious disease endemic in our country and affects all systems. We aimed to evaluate clinical, laboratory findings and treatment outcomes of uncomplicated brucellosis in our study. Materials and Methods: Patients with uncomplicated brucellosis and with no relapse were evaluated from four different cities. Demographic data, clinical, laboratory and radiological findings of follow-up and treatment of 101 patients were recorded in forms. Clinical response (healing, treatment failure, relapse, etc.), treatment side effects, compliance and treatment discontinuation were evaluated at one-year follow-up. Results: The most common risk factors for brucellosis were detected respectively as fresh cheese/dairy product consumption (82.2%), rural area life (71.3%), brucellosis in family and surroundings (42.6%), animal husbandry (27.7%), and brucellosis in animals (24.8%). 80.2% of the patients were evaluated as acute brucellosis. Clinically, fatigue, sweating, loss of appetite, fever, body aches, arthralgia; elevated erythrocyte sedimentation rate, elevated C-reactive protein, elevated liver function tests, anemia and thrombocytopenia were the most frequent findings in laboratory examinations, respectively. In patients with brucellosis, blood culture positivity was 68%, Rose Bengal slide agglutination test was 97.1%, and tube agglutinin test positivity was 96.8%. The most preferred treatment regimen (90%) was doxycycline and rifampicin for 45 days, and treatment response was 89%. In five of the patients, treatment was changed due to doxycycline-linked gastrointestinal side effects. Relapses were seen in 4.9% of all patients. Conclusion: In brucellosis, delay in diagnosis increases the incidence of complications and the tendency to become chronic. For this reason, brucellosis must be considered in patients referred to health institutions with complaints such as fever, sweating and joint pain. Since uncomplicated brucellosis was evaluated in this study, it was seen that the majority of the patients were acute onset and had a high response rate to treatment.
dc.identifier.doi10.5578/flora.68436
dc.identifier.eissn1300-932X
dc.identifier.endpage61
dc.identifier.issn1300-932X
dc.identifier.issue1
dc.identifier.startpage54
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/16957
dc.identifier.volume25
dc.identifier.wosWOS:000523303400008
dc.language.isotr
dc.publisherBILIMSEL TIP YAYINEVI
dc.relation.ispartofFLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBrucellosis
dc.subjectTransmission
dc.subjectDiagnosis
dc.subjectTreatment
dc.subjectRelapse
dc.subjectBrucella melitensis
dc.subjectOFLOXACIN-RIFAMPIN
dc.subjectMANIFESTATIONS
dc.subjectCOMPLICATIONS
dc.subjectMicrobiology
dc.titleEvaluation of Laboratory, Clinical and Treatment Results in Patients with Uncomplicated Brucellosis
dc.typeArticle
dspace.entity.typePublication
rdl.citation.trdizin0
rdl.citation.wos1
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.departmentT.C. SAĞLIK BAKANLIĞI
rdl.departmentÖzel Kuruluş
rdl.oa.statusgold
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexEmerging Sources Citation Index (ESCI)